Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

 
 
Session Overview
Session
KL34: Innovations for improving treatment of CKD
Time:
Wednesday, 11/Sept/2024:
11:15am - 12:45pm

Session Chair: Andrea Remuzzi
Session Chair: Angel ARGILES
Location: K1


Show help for 'Increase or decrease the abstract text size'
Presentations
11:15am - 11:35am

Novel clinical aspects of CKD: the burden of vascular calcification and new endeavours for its prevention and treatment

Angel ARGILES

RD NEPHROLOGIE, France



11:35am - 11:45am

DEVELOPMENT OF OUTSIDE-IN FILTRATION HOLLOW FIBERS FOR THE ARTPLAC DEVICE.

LUCIA ROMANO1, RENSKE LUITEN1, RAVI SELVAGANAPATHY2, NIELS ROCHOW3, CHRISTOPH FUSCH3, JUTTA ARENS4, ODYL.E.M. TER BEEK1, DIMITRIOS STAMATIALIS1, ARTPLAC RESEARCH CONSORTIUM5

1University of Twente, Enschede, the Netherlands,Faculty of Science and Technology, Advanced Organ bioengineering and Therapeutics (AOT); 2McMaster University, Hamilton, ON - Canada, Department of Mechanical Engineering; 3Klinikum Nurnberg, Nuremberg, German; 4University of Twente, Enschede, the Netherlands,Faculty of Engineering Technologies, Department of Biomechanical Engineering, Engineering Organ Support Technologies; 5HORIZON-EIC-2022-PATHFINDEROPEN-01, Grant agreement ID: 101099596

289.pdf


11:45am - 11:55am

Changes in the glomerular macrophage index (GMI) between two consecutive biopsies and the association to renal transplant graft survival

Salmir Nasic1,2, Johan Mölne3,4, Marie Eriksson5, Bernd Stegmayr6, Henri Afghahi2,7, Björn Peters2,7

1Region Västra Götaland, Skaraborg Hospital, Research, Education, Development and Innovation Department, Skövde/Sweden; 2Department of Molecular and Clinical Medicine, Institute of Medicine, the Sahlgrenska Academy at University of Gothenburg, Gothenburg/Sweden; 3Institute of Biomedicine, Department of Laboratory Medicine, University of Gothenburg, Gothenburg/Sweden; 4Region Västra Götaland, Sahlgrenska University Hospital, Clinical Pathology, Gothenburg/Sweden; 5Department of Statistics, Umeå School of Business, Economics and Statistics, Umeå University, Umeå/Sweden; 6Public Health and Clinical Medicine Umeå University, Umeå/Sweden; 7Region Västra Götaland, Skaraborg Hospital, Department of Nephrology, Skövde/Sweden

112.pdf


11:55am - 12:05pm

Questioning a paradigm: Should dialysis membranes be impermeable for albumin?

Joerg Vienken1, Gerd Klinkmann2

1NedTech Consultants, Germany; 2University Clinic Rostock, Germany

256.pdf


12:05pm - 12:15pm

HEMODIALYSIS WITHOUT AN EXTRACORPOREAL BLOOD CIRCUIT? MODULAR DESIGN CAN MEET PATIENT PREFERENCES & STANDARDS

Fokko Pieter Wieringa1,2

1IMEC, Holst Centre, 5656 AE Eindhoven, The Netherlands; 2Department of Nephrology and Hypertension, University Medical Centre Utrecht, Utrecht, The Netherlands

193.pdf


12:15pm - 12:25pm

GREEN AND EFFICIENT DIALSYIS: A CONTRADICTION IN TERMS?

Sunny Eloot, Wim Van Biesen, Floris Vanommeslaeghe

Ghent University Hospital, Belgium

196.pdf